- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
Indomethacin
別名: Indometacin,NSC-77541 中文名稱：吲哚美辛
Indomethacin是一種非選擇性的COX1和COX2的抑制劑，IC50分別為0.1 μg/mL和5 μg/mL。常用于降低發(fā)熱、減緩疼痛、僵硬和腫脹。
Indomethacin Chemical Structure
CAS: 53-86-1
產(chǎn)品質(zhì)控
批次：
純度：
99.99%
99.99
Indomethacin相關產(chǎn)品
相關信號通路圖
細胞實驗數(shù)據(jù)示例
| 細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
|---|---|---|---|---|---|
| THP1 cells | Function assay | 100 μM | 30 mins | Irreversible inhibition of COX-1 in human THP1 cells assessed as inhibition of arachidonic acid-induced TXB2 formation at 100 uM incubated for 30 mins followed by compound washout measured 30 mins post arachidonic acid challenge by radioimmunoassay | 23651359 |
| MDA-MB-231 cells | Function assay | 100 μM | 30 mins | Irreversible inhibition of COX-1 in human MDA-MB-231 cells assessed as inhibition of arachidonic acid-induced PGE2 formation at 100 uM incubated for 30 mins followed by compound washout measured 30 mins post arachidonic acid challenge by radioimmunoassay | 23651359 |
| LNCAP cells | Function assay | 30 μM | 48 h | Inhibition of AKR1C3 (unknown origin)-mediated testosterone-17beta-glucuronide formation expressed in human LNCAP cells at 30 uM after 48 hrs in presence of 4-androstene-3,17-dione | 23432095 |
| A549 cells? | Function assay | 10 μM | Inhibition of mPGES1 in human A549 cells assessed as inhibition of IL-1-beta-induced PGE2 formation at 10 uM by cell-intact assay | 19053751 | |
| HepG2 cells | Function assay | 100 μM | Inhibition of MRP1-mediated doxorubicin efflux in doxorubicin resistant human HepG2 cells at 100 uM by flow cytometry | 20455578 | |
| HeLa cells | Function assay | 20 mins | Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay, EC50=0.14 nM | 23432095 | |
| SF-9 insect cells | Function assay | 20 Mins | Inhibition of human COX2 expressed in SF-9 insect cells assessed as conversion of [14C]-arachidonic acid to [14C]-prostaglandins preincubated for 20 mins by thin-layer chromatography analysis, IC50=0.75 μM | 21524587 | |
| mouse RAW264.7 cells | Function assay | 24 h | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay, IC50=1.25 μM | 24806310 | |
| mouse BV2 cells | Function assay | 24 h | Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay, IC50=7.1 μM | 24042007 | |
| mouse BV2 cells | Cytotoxicity assay | 24 h | Cytotoxicity against mouse BV2 cells assessed as maximum non-toxic concentration after 24 hrs by MTT assay | 23711917 | |
| J774 cells | Function assay | In vitro inhibitory activity against Prostaglandin G/H synthase 1 in murine J774 cells, IC50=2 nM | 15857149 | ||
| U-937 cells | Function assay | In vitro inhibitory activity against human Prostaglandin G/H synthase 1 (COX-1) in U-937 cells, IC50=2 nM | 12877584 | ||
| rat synovial cells | Function assay | In vitro inhibitory effect on production of prostaglandin E2 (PGE2) in rat synovial cells, IC50=2.9 nM | 10821716 | ||
| 143982 cells | Function assay | In vitro inhibitory activity against human Prostaglandin G/H synthase 2 (COX-2) in 143982 cells, IC50=9 nM | 12877584 | ||
| CHO cells | Function assay | In vitro inhibitory potency against human COX-1 in stably transfected chinese hamster ovary (CHO) cells, IC50=18 nM | 10576684 | ||
| RBL-1 cell line | Function assay | Inhibition of Prostaglandin G/H synthase in intact RBL-1 cell line, IC50=0.5 μM | 2115586 | ||
| human 2008 cells | Function assay | Inhibition of human MRP1 in human 2008 cells, IC50=12 μM | 18707884 | ||
| 點擊查看更多細胞系數(shù)據(jù) | |||||
生物活性
| 產(chǎn)品描述 | Indomethacin是一種非選擇性的COX1和COX2的抑制劑，IC50分別為0.1 μg/mL和5 μg/mL。常用于降低發(fā)熱、減緩疼痛、僵硬和腫脹。 | ||||
|---|---|---|---|---|---|
| 靶點 |
|
| 體外研究(In Vitro) | ||||
| 體外研究活性 | Indomethacin以劑量依賴性方式抑制一種β-連環(huán)蛋白/ TCF響應報道基因的轉(zhuǎn)錄。Indomethacin也下調(diào)了β-連環(huán)蛋白/ TCF轉(zhuǎn)錄針對細胞周期蛋白D1。Indomethacin通過調(diào)節(jié)TCF活動而不破壞β-連環(huán)蛋白/ TCF復合物的形成減少β-連環(huán)蛋白/ TCF-應答基因的轉(zhuǎn)錄。[1] | |||
|---|---|---|---|---|
| 體內(nèi)研究(In Vivo) | ||
| 體內(nèi)研究活性 | 大鼠局灶性腦缺血后，Indomethacin增加所有細胞系的BrdU+細胞并減少小膠質(zhì)細胞/單核細胞活化。[2] Indomethacin（7.5 毫克/千克，1次注射）在遠端空腸和回腸近端產(chǎn)生急性損傷和炎癥，在三天內(nèi)達到最大，一周內(nèi)完全解決。Indomethacin（每日2次皮下注射）產(chǎn)生一個更廣泛的和慢性炎癥，持續(xù)以活性形式存在于75％的大鼠中至少兩周。[3] 在SKH：HR-1-HRBR無毛小鼠中，Indomethacin（4ppm）減少腫瘤增產(chǎn)達78％。[4] Indomethacin（20 毫克/千克，口服）增加胃糜爛的總面積和大鼠的胃粘膜脂質(zhì)過氧化物的濃度。 Indomethacin增加α-生育酚：血清總膽固醇的比例。 Indomethacin抑制胃粘膜糜爛和脂質(zhì)過氧化物在胃粘膜的增加，血清α-生育酚的還原的減少。[5] | |
|---|---|---|
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06031363 | Completed | Pancreatitis|Cholangiopancreatography Endoscopic Retrograde|Indomethacin |
The First Affiliated Hospital of Soochow University |
November 1 2022 | Not Applicable |
| NCT04821323 | Completed | Healthy |
Janssen Research & Development LLC |
March 10 2021 | Early Phase 1 |
| NCT04025177 | Withdrawn | Patent Ductus Arteriosus After Premature Birth |
University of Manitoba|St. Boniface Hospital|Health Sciences Centre Winnipeg Manitoba|University at Buffalo |
January 2020 | Phase 2 |
| NCT03967483 | Unknown status | Headache Migraine |
Anne Ducros|French Society for the Study of Migraine Headache |
June 1 2019 | -- |
化學信息&溶解度
| 分子量 | 357.79 | 分子式 | C19H16ClNO4 |
| CAS號 | 53-86-1 | SDF | Download Indomethacin SDF |
| Smiles | CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O | ||
| 儲存條件(自收到貨起) | |||
|
體外溶解度 |
DMSO : 72 mg/mL ( (201.23 mM) ；DMSO吸濕會降低化合物溶解度，請使用新開封DMSO) Ethanol : 24 mg/mL (67.07 mM) Water : Insoluble |
摩爾濃度計算器 |
|
體內(nèi)溶解度 現(xiàn)配現(xiàn)用，請按從左到右的順序依次添加，澄清后再加入下一溶劑 |
動物體內(nèi)配方計算器 | ||||
實驗計算
動物體內(nèi)配方計算器（澄清溶液）
第一步：請輸入基本實驗信息（考慮到實驗過程中的損耗，建議多配一只動物的藥量）
mg/kg
g
μL
只
第二步：請輸入動物體內(nèi)配方組成（配方適用于不溶于水的藥物；不同批次藥物配方比例不同，請聯(lián)系Selleck為您提供正確的澄清溶液配方）
% DMSO
%
% Tween 80
% ddH2O
%DMSO
%
計算結果：
工作液濃度： mg/ml；
DMSO母液配制方法： mg 藥物溶于μL DMSO溶液（母液濃度mg/mL，注：如該濃度超過該批次藥物DMSO溶解度，請先聯(lián)系Selleck）；
體內(nèi)配方配制方法：取μL DMSO母液，加入μL PEG300，混勻澄清后加入μL Tween 80，混勻澄清后加入μL ddH2O，混勻澄清。
體內(nèi)配方配制方法：取μL DMSO母液，加入μL Corn oil，混勻澄清。
注意：1. 首先保證母液是澄清的；
2.一定要按照順序依次將溶劑加入，進行下一步操作之前必須保證上一步操作得到的是澄清的溶液，可采用渦旋、超聲或水浴加熱等物理方法助溶。
技術支持
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段，您遇到的任何問題，均可以通過撥打我們的熱線電話400-668-6834，或者技術支持郵箱tech@selleck.cn，直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。
如果有其他問題，請給我們留言。
* 必填項
Tags: buy Indomethacin | Indomethacin supplier | purchase Indomethacin | Indomethacin cost | Indomethacin manufacturer | order Indomethacin | Indomethacin distributor
